Team 20

NASA Crew Member Cardiovascular Monitoring System

Team Members:

Brandon Duty

Jacob Hernandez

Kaitlyn Janssen

Martin Perez

Jonathan Scirone

Team Mentors:

Dr. Vikram Kodibagkar - Arizona State University

Kimia Seyedmadani - Research Operation Integration (ROI) Group at NASA

Keith Tucker - Research Operation Integration (ROI) Group at NASA


YouTube Link:
View the video link below before joining the zoom meeting

Zoom Link:
https://asu.zoom.us/j/85251472767

Abstract

As mankind ventures ever further into the expanse of space, a great amount of emphasis must be placed on accounting for the hazards of space exploration, namely physiological deconditioning. From the moment astronauts enter an environment of reduced gravity, the human body begins to experience a multitude of physiological adaptations due to the fluid shift induced by weightlessness. In the cardiovascular system alone, microgravity environments can contribute to changes in blood pressure, blood oxygenation, and heart rate. To develop countermeasures for such adaptations, we have created a dominant concept for monitoring cardiovascular biometrics through the implementation of industry best practice product development tools such as the House of Quality and Quality Systems Regulations. After consulting lead users, it was determined that any potential monitoring system must remain cost effective, provide useful insights into the health of astronauts, and have a functional lifespan that does not infringe on its efficient utilization. To this end, Interstellar Systems proposes the AeroLife Vital Monitoring System. As an all-in-one bioinstrumentation device, the AeroLife VMS uses a variety of sensors to monitor cardiovascular health. Our device concept offers the non-invasive, continuous, and accurate acquisition of spO2, heart rate, blood pressure, and HRV. We intend to create this device using a combination of microcontroller, ECG, blood pressure, and pulse oximetry in materials systems. To validate the functionality of our system, technical model development has provided greater insights into the technical feasibility of our device. Overall, our research indicates that our target specifications stand as an achievable target in line with the cost models and efficacy of our competitors in the cardiovascular health monitoring industry. Moreover, we believe that our diverse combination of skill sets and backgrounds, in addition to consultation from our mentors and other experts, will allow us to successfully develop our dominant product concept.